MK

Monica Kaile

Active Director Director DIN 07329652
DIN 07329652 First appointment Oct 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2015
Shareholding value •••• Premium profile

About Monica Kaile

Data last updated:

Monica Kaile is a Director at Perk Pharmaceuticals Limited (since 2015). The company operates in Pharma. Perk Pharmaceuticals Limited reported revenue of ₹15.71 Cr (FY 2020).

DIN 07329652
Primary Designation Director
Industry Pharma
First Appointment 21 Oct 2015
Oldest Company Age 45 yrs
Largest company Perk Pharmaceuticals Limited · ₹15.71 Cr (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Perk Pharmaceuticals Limited L24231UP1981PLC005400
Director21 Oct 20151981₹15.71 Cr (FY 2020)Active

Board colleagues of Monica Kaile

NameDINCompanyDesignation
Krishna Kaile00987703Perk Pharmaceuticals LimitedManaging Director
Ritu Kaile07329665Perk Pharmaceuticals LimitedWhole-Time Director

Directorship timeline

Open interactive timeline →
Perk Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Monica Kaile

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Monica Kaile

Monica Kaile currently holds 1 directorship: Perk Pharmaceuticals Limited (Director, since 21 Oct 2015, revenue ₹15.71 Cr (FY 2020)).

Monica Kaile was first appointed on 21 Oct 2015 as Director at Perk Pharmaceuticals Limited.

The current boards of Monica Kaile's companies include Krishna Kaile (Perk Pharmaceuticals Limited), Ritu Kaile (Perk Pharmaceuticals Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available